English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/61321
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: Protective effects of LXR activation

AuthorsCermenati, G.; Abbiati, F.; Cermenati, S.; Brioschi, E.; Volonterio, Alessandro; Cavaletti, G.; Sáez, Enrique; Fabiani, Emma de; Crestani, M.; García-Segura, Luis M. ; Melcangi, R. C.; Caruso, D.; Mitro, N.
Issue Date2012
PublisherAmerican Society for Biochemistry and Molecular Biology
CitationJournal of Lipid Research 53: 300- 310 (2012)
AbstractDiabetic peripheral neuropathy (DPN) is characterized by myelin abnormalities; however, the molecular mechanisms underlying such deficits remain obscure. To uncover the effects of diabetes on myelin alterations, we have analyzed myelin composition. In a streptozotocintreated rat model of diabetic neuropathy, analysis of sciatic nerve myelin lipids revealed that diabetes alters myelin's phospholipid, FA, and cholesterol content in a pattern that can modify membrane fluidity. Reduced expression of relevant genes in the FA biosynthetic pathway and decreased levels of the transcriptionally active form of the lipogenic factor sterol-regulatory element binding factor-1c (SREBF-1c) were found in diabetic sciatic nerve. Expression of myelin's major protein, myelin protein zero (P0), was also suppressed by diabetes. In addition, we confirmed that diabetes induces sciatic nerve myelin abnormalities, primarily infoldings that have previously been associated with altered membrane fluidity. In a diabetic setting, synthetic activator of the nuclear receptor liver X receptor (LXR) increased SREBF-1c function and restored myelin lipid species and P0 expression levels to normal. These LXR-modulated improvements were associated with restored myelin structure in sciatic nerve and enhanced performance in functional tests such as thermal nociceptive threshold and nerve conduction velocity. These findings demonstrate an important role for the LXR-SREBF-1c axis in protection from diabetes-induced myelin abnormalities. Copyright © 2012 by the American Society for Biochemistry and Molecular Biology, Inc.
URIhttp://hdl.handle.net/10261/61321
DOI10.1194/jlr.M021188
Identifiersdoi: 10.1194/jlr.M021188
issn: 0022-2275
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.